Drug Maker Calls DEA Admin Judge Appointment Flawed
An administrative judge with the U.S. Drug Enforcement Administration hit pause Wednesday on an agency dispute with a manufacturer of medications treating attention-deficit/hyperactivity disorder, a day after the company filed a...To view the full article, register now.
Already a subscriber? Click here to view full article